Muropeptide exerted the immune activation function through the signal transduction of innate immune sensing protein NOD2, increased the proportion of CD8+ T cells in tumor infiltrating lymphocytes and expressing granzyme B. Tumor immune microenvironment was improved and the efficacy of multiple immunotherapeutic mAbs was enhanced [54] (Table 1). The gene discussed is GZMB; the disease is neoplasm.